Literature DB >> 23120681

Management of unresectable head and neck cancers - a retrospective analysis at a rural medical college of India.

Aloke Ghosh Dastidar1, Somnath Saha, Abhishekh Srivastava, Debdulal Chakroborty, Balaram Sardar.   

Abstract

OBJECTIVE: To study the natural course of disease in patients of advanced squamous cell carcinoma of head and neck (SCCHN) admitted in a rural tertiary hospital and to formulate an acceptable protocol of management and their prognosis. STUDY
DESIGN: A 5-year retrospective analysis of patients of advanced SCCHN attended in the department of Radiotherapy and admitted at department of ENT at B. S. Medical College, Bankura, West Bengal were analyzed for the present study.
SETTING: B. S. Medical College, Bankura at West Bengal, which is a rural medical college and act as tertiary referral, center for three district of West Bengal namely Midnapur, Purulia, Bankura, part of Burdwan and adjoining area of Jharkhand state. PATIENTS: We investigated 100 patients in our hospital who presented with advanced and in-operable stage of SCCHN. ELIGIBILITY CRITERIA: Biopsy proved cases of SCCHN in stage III, stage IVA and stage IVB which is surgically unresectable and without any past history of radiotherapy and chemotherapy were included in this study. KEY DEMOGRAPHIC FEATURES: Eighty-nine men and 11 female with advanced SCCHN were included in this study. Their median age was 48 years (36-78 years) with a median weight of 44 kg and median Karnofsky score 70.
INTERVENTIONS: Different types of palliative surgical intervention like Ryles' tube insertion (16%), feeding jejunostomy (11%), tracheostomy (60%) and arterial ligation (2%) was done to relieve the symptoms. Forty-three patients received chemoradiation and 22 patients received only radiotherapy. Best supportive care was provided to 35 patients. OUTCOME: Twenty-nine percent of patients had partial response in terms of disease control and none had complete response.
CONCLUSION: Symptomatic relief of respiratory obstruction, dysphagia and pain constitute the mainstay of treatment in the present study. A short course of radiotherapy is found to be effective in control of symptoms and helps to improve the quality-of-life. Complete response to therapy in advanced head and neck squamous cell carcinoma with a poor nutritional status is very difficult to achieve.

Entities:  

Keywords:  Head and neck cancer; Palliation; Squamous cell carcinoma; Terminal care of cancer

Year:  2010        PMID: 23120681      PMCID: PMC3450164          DOI: 10.1007/s12070-010-0006-8

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  22 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

2.  A comparison of radiotherapy or radiochemotherapy with symptomatic treatment alone in patients with advanced head and neck carcinomas.

Authors:  A L Carvalho; J V Salvajoli; L P Kowalski
Journal:  Eur Arch Otorhinolaryngol       Date:  2000       Impact factor: 2.503

3.  Outcome of treatment of 160 patients with squamous cell carcinoma of the neck staged N3a.

Authors:  J H Isaacs; J R Schnitman
Journal:  Head Neck       Date:  1990 Nov-Dec       Impact factor: 3.147

4.  Standard chemotherapy in squamous cell head and neck cancer: what we have learned from randomized trials.

Authors:  G P Browman; L Cronin
Journal:  Semin Oncol       Date:  1994-06       Impact factor: 4.929

5.  Radiation therapy for head and neck cancers in the elderly.

Authors:  A Lusinchi; J Bourhis; P Wibault; A M Le Ridant; F Eschwege
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-04       Impact factor: 7.038

6.  Squamous cell carcinomas metastatic to cervical lymph nodes from an unknown head and neck mucosal site treated with radiation therapy with palliative intent.

Authors:  H S Erkal; W M Mendenhall; R J Amdur; D B Villaret; S P Stringer
Journal:  Radiother Oncol       Date:  2001-06       Impact factor: 6.280

7.  Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study.

Authors:  Bidhu K Mohanti; Hombaiah Umapathy; Sudhir Bahadur; Alok Thakar; Sushmita Pathy
Journal:  Radiother Oncol       Date:  2004-06       Impact factor: 6.280

8.  Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial.

Authors:  Cai Grau; Jai Prakash Agarwal; Kaukab Jabeen; Abdul Rab Khan; Sarath Abeyakoon; Tatiana Hadjieva; Ibrahim Wahid; Sedat Turkan; Hideo Tatsuzaki; Ketayun A Dinshaw; Jens Overgaard
Journal:  Radiother Oncol       Date:  2003-04       Impact factor: 6.280

Review 9.  Chemotherapy for recurrent and metastatic head and neck cancer.

Authors:  H A Pinto; C Jacobs
Journal:  Hematol Oncol Clin North Am       Date:  1991-08       Impact factor: 3.722

10.  Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma.

Authors:  Jacek Jassem; Rodryg Ramlau; Armando Santoro; Wolfgang Schuette; Assad Chemaissani; Shengyan Hong; Johannes Blatter; Susumu Adachi; Axel Hanauske; Christian Manegold
Journal:  J Clin Oncol       Date:  2008-04-01       Impact factor: 44.544

View more
  1 in total

1.  Initial Experience of Head and Neck Cancer Patients Treated in an Oncologist Led Palliative Cancer Care Clinic at a Tertiary Cancer Care Center in Uttar Pradesh: Is the Initiative of a Full-fledged Palliative Care for Cancer Patients Justified.

Authors:  Punita Lal; Mranalini Verma; Gaurav Kumar; Resham Shrivastava; Shaleen Kumar
Journal:  Indian J Palliat Care       Date:  2016 Oct-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.